PHASE I DOSE-ESCALATION STUDY OF THE MULTIKINASE INHIBITOR LENVATINIB IN PATIENTS WITH ADVANCED SOLID TUMORS AND IN AN EXPANDED COHORT OF PATIENTS WITH MELANOMA
Sunday, July 26, 2015
Sunday, July 26, 2015
Discover more posts like this.
A unique clinical trial identification number generated by Mary Crowley Cancer Research.
The cancer type reflective of your diagnosis. If you do not see your cancer type, it may be under a different name, type in the box to search for your specific condition.
A term used to describe certain genes, proteins, and other molecules that are involved in the growth, spread, and survival of cancer cells and may be used as targets for cancer treatment.
A group of medications and other compounds that have similar chemical structures, similar modes/mechanisms of action, and/or are used to treat similar diseases.
A unique identification code given to each clinical study record registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
Whether a manuscript is published by the pharmaceutical sponsor relating to that specific clinical trial.